Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Puig €2.6 billion IPO
Puig’s Class B shares are listed on the Spanish Stock Exchanges
Finastra Group $5.32 billion refinancing
We advised the administrative agent, lead arrangers and lenders on the refinancing
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
BBVA $2 billion SEC-registered senior preferred notes offering
Davis Polk advised Banco Bilbao Vizcaya Argentaria, S.A. on its SEC-registered offering of $1.2 billion fixed-rate senior…
Oesterreichische Kontrollbank $1.5 billion notes offering
Davis Polk advised the underwriters on an SEC-registered offering on Schedule B by Oesterreichische Kontrollbank…
Max Stock NIS 621 million international IPO
Davis Polk advised Max Stock Ltd., as the issuer and Moose Holdco Ltd., Uri Max Ltd. and Oria & Iris Ltd. LP, as the…
Broadstone Acquisition $300 million IPO
Davis Polk advised the underwriter in connection with the initial public offering of 30,000,000 units of Broadstone…
Prime Impact Acquisition I $300 million IPO
Davis Polk advised the underwriters in connection with the initial public offering of 30,000,000 units of Prime Impact…
Anglo American $1.5 billion notes offering
Davis Polk advised the joint bookrunners on an offering of $1 billion aggregate principal amount of 2.625% senior notes due…
Mizuho Financial Group $2 billion senior notes offering
Davis Polk advised the joint bookrunners and lead managers in connection with Mizuho Financial Group, Inc.’s SEC-registered…
Tencent Music $800 million debut SEC-registered notes offering
Davis Polk advised Tencent Music Entertainment Group on its debut SEC-registered notes offering, consisting of $300 million…
Emirate of Abu Dhabi $5 billion notes offering
Davis Polk advised the joint lead managers in connection with a Rule 144A/Regulation S offering by the Emirate of Abu Dhabi…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate…